The role of T lymphocytes in bone metabolism
- PMID: 16313347
- DOI: 10.1111/j.0105-2896.2005.00324.x
The role of T lymphocytes in bone metabolism
Abstract
Recent findings from animal models suggest that the bone loss induced by estrogen deficiency may stem in large measure from a pathological upregulation of the adaptive immune response. While the role of activated T cells in the osteoporosis driven by inflammatory conditions and infection has been well documented, only recently has the role of T cells in the bone destruction associated with estrogen deficiency begun to be appreciated. In vivo and in vitro models of postmenopausal osteoporosis demonstrate that estrogen deficiency leads to an increase in the adaptive immune function that culminates in an increased production of tumor necrosis factor alpha (TNF) by activated T cells. TNF increases osteoclast (OC) formation and bone resorption both directly and by augmenting the sensitivity of maturing OCs to the essential osteoclastogenic factor receptor activator of nuclear factor kappaB ligand. The activation and expansion of TNF-producing T cells are key steps in estrogen deficiency-driven bone loss and are regulated by multiple interacting cytokines including transforming growth factor-beta, interleukin-7, and interferon-gamma, as well as by the process of antigen presentation. Herein, we review the experimental evidence that suggests estrogen prevents bone loss by regulating T-cell function and immune cell bone interactions.
Similar articles
-
Estrogen regulation of immune cell bone interactions.Ann N Y Acad Sci. 2006 Apr;1068:256-74. doi: 10.1196/annals.1346.030. Ann N Y Acad Sci. 2006. PMID: 16831927 Review.
-
T cells and post menopausal osteoporosis in murine models.Arthritis Res Ther. 2007;9(2):102. doi: 10.1186/ar2126. Arthritis Res Ther. 2007. PMID: 17349065 Free PMC article.
-
Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency.Minerva Med. 2004 Apr;95(2):125-32. Minerva Med. 2004. PMID: 15272247 English, Italian.
-
Post-menopausal osteoporosis: is it an autoimmune disease?J Endocrinol Invest. 2005;28(10 Suppl):43-7. J Endocrinol Invest. 2005. PMID: 16550722 Review.
-
T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis.Ann N Y Acad Sci. 2007 Nov;1116:360-75. doi: 10.1196/annals.1402.068. Ann N Y Acad Sci. 2007. PMID: 18083938 Review.
Cited by
-
The role of IL-1β in the bone loss during rheumatic diseases.Mediators Inflamm. 2015;2015:782382. doi: 10.1155/2015/782382. Epub 2015 Apr 12. Mediators Inflamm. 2015. PMID: 25954061 Free PMC article. Review.
-
Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblast-specific regulation of the insulin-like growth factor binding protein 4 gene.Mol Endocrinol. 2008 Feb;22(2):361-79. doi: 10.1210/me.2007-0292. Epub 2007 Oct 25. Mol Endocrinol. 2008. PMID: 17962383 Free PMC article.
-
Impact of cytokines and T lymphocytes upon osteoclast differentiation and function.Arthritis Res Ther. 2007;9(2):103. doi: 10.1186/ar2141. Arthritis Res Ther. 2007. PMID: 17381830 Free PMC article. Review.
-
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss.Eur J Immunol. 2009 Oct;39(10):2831-9. doi: 10.1002/eji.200939670. Eur J Immunol. 2009. PMID: 19731364 Free PMC article.
-
Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents.PLoS One. 2008 Jul 9;3(7):e2615. doi: 10.1371/journal.pone.0002615. PLoS One. 2008. PMID: 18612428 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
